STOCK TITAN
  1. Home
  2. Sec-filings
  3. EVGN
  4. [6-K] EVOGENE LTD. Current Report (Foreign Issuer)

[6-K] EVOGENE LTD. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock EVGN logo
Evogene

NASDAQ:EVGN

EVGN Rankings

#6072 Ranked by Market Cap
N/A Ranked by Dividends

EVGN Latest News

Aug 28, 2025
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
Aug 19, 2025
Evogene Reports Second Quarter 2025 Financial Results
Aug 12, 2025
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
Jul 29, 2025
Evogene Schedules Second Quarter 2025 Financial Results Release
Jul 8, 2025
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL

EVGN Latest SEC Filings

Sep 10, 2025
[6-K] EVOGENE LTD. Current Report (Foreign Issuer)
Aug 19, 2025
[6-K] EVOGENE LTD. Current Report (Foreign Issuer)
Aug 18, 2025
[6-K] EVOGENE LTD. Current Report (Foreign Issuer)
Aug 11, 2025
[6-K] EVOGENE LTD. Current Report (Foreign Issuer)
Jul 8, 2025
[6-K] EVOGENE LTD. Current Report (Foreign Issuer)

EVGN Stock Data

10.77M
8.63M
0.96%
1.61%
1.23%
Biotechnology
Healthcare
Link
Israel
Rehovot